Phenogen Sciences, a subsidiary of Genetic Technologies, has unveiled a non-invasive genetic risk assessment test for women with estrogen-receptor positive breast cancer. The BREVAGen uses patients oral-swab samples to calculate patient's ...
Tags: non-invasive genetic risk assessment test, cancer test
The US Army has entered into an agreement to buy Smiths Medical's CADD-Solis ambulatory infusion portable pain management system. Under the agreement, US Army will use CADD-Solis system at its Madigan Army Medical center at Joint Base ...
Tags: Smiths Medical, pain management system, CADD-Solis system
University of California, San Francisco's (UCSF) Helen Diller Family Comprehensive Cancer Center has installed Accuray's TomoTherapy system to provide treatment options for cancer patients. The TomoTherapy system, designed for integrated, ...
Tags: Accuray Tomotherapy System, Accuray's TomoTherapy system
The Carol and Ray Neag Comprehensive Cancer Center and Christiana Care Helen F. Graham Cancer Center have ordered for RaySearch Laboratories' RayStation treatment planning system. The Carole Cancer Center will use RayStation for ...
Tags: clinical research, clinical technology, RaySearch, RayStation
Paris based cancer center Institut Curie has ordered four radiotherapy treatment systems - three Varian TrueBeam systems and a Novalis Tx machine - from Varian Medical Systems. The cancer institute has purchased the devices to replace ...
Tags: radiotherapy treatment system, medical device, clinical research
Magdeburg-based Dornheim Medical Images has said that three-dimensional images facilitate medical diagnoses. Dornheim's program, designed for creating three-dimensional images, uses cross-sectional images and the highlighted areas of ...
Tags: clinical research, clinical application, clinical technology
Affibody has entered into a collaboration agreement with GE Healthcare to develop a Her2-targeted PET imaging agent for detecting breast and gastric cancer. The clinical trials for the Her2-targeted PET imaging agent is scheduled to ...
Tags: company cooperation, clinical research, breast cancer, gastric cancer
Allegro Diagnostics has completed patient enrollment in 1,320-patient Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer II (AEGIS II) trial for BronchoGen genomic test. BronchoGen, which is built on the company's ...
Tags: clinical trial, clinical research, lung cancer molecular diagnostic
An Innisfil woman has joined the local"Armour Lip Charmours"Movember team in an effort to increase awareness and raise funds for prostate cancer research. BARRIE,ON,November 21,2012/24-7PressRelease/--An Innisfil woman has joined ...
Tags: Armour Lip Charmours, Innisfil Woman, Men's Health Issues
Medcan Clinic, a private health care clinic in Canada, has entered into a collaboration agreement with Pathway Genomics. Under the agreement, Pathway Genomics will allow Medcan's patients to use its Personal Genome Test. Using only a ...
Tags: Medcan Clinic, Pathway Genomics, collaboration agreement
Medivation and Astellas Pharma have announced FDA approval for Xtandi (enzalutamide) capsules to treat metastatic castration-resistant prostate cancer in patients with previously received docetaxel. Medivation and Astellas expect to make ...
Tags: Medivation, Astellas, FDA
Roche is planning to invest CHF240m ($259m) to construct a new diagnostics production facility at its Penzberg biotechnology center in Munich, Germany. The new 26,000ft2 plant, which will be known as Diagnostics Operations Complex II ...
Astellas Pharma US is seeking FDA approval for Tarceva tablets to treat non-small cell lung cancer patients (NSCLC) with tumors containing epidermal growth factor receptor (EGFR) that triggers mutations. The company submitted a ...
China is a vast country with a long history and diverse nationalities, and therefore there are a great number of widespread ballads and folk songs. Among them, Jasmine Flower stands out for its beautiful and catchy tune. It's so popular ...
Tags: ballad, jasmine flower, south of the Yangtze River, classical opera
The Federal Institute for Drugs and Medical Devices, the German regulatory authority, has approved Helix BioPharma's clinical trial application for a European Phase III efficacy trial of Topical Interferon Alpha-2b in patients with ...